Azienda Ospedaliera Universitaria Federico II di Napoli
Naples 80131
4 studies enrolling now · 11 studies all time
What they study most
Acute Myocardial Infarction (AMI), Breast Cancer, Cardiovascular Disease, Cardiovascular Risk, Chronic Kidney Disease, Haemophilia A, Heart Failure, Huntington Disease, Inflammation, MPN-associated Myelofibrosis, Obesity, Overweight
Studies at this site
- A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A — Recruiting now
- Pridopidine Phase 3 Study in Huntington's Disease — Recruiting now
- Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects — Recruiting now
- ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
- ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
- REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels — Running, not enrolling
- A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor — Completed
- Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM — Enrolling by invitation
- Levels of Inflammation in People With Cardiovascular Disease (POSEIDON) — Completed
- Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed
- Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence — Completed